FDG PET/CT in the management of colorectal and anal cancers

Ankit Agarwa, Charles Marcus, Jennifer Xiao, Prachi Nene, Lisa A. Kachnic, Rathan M. Subramaniam

Research output: Contribution to journalReview article

29 Scopus citations

Abstract

OBJECTIVE. CT remains the imaging modality of choice in the diagnosis of colorectal cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of MRI and PET/CT. This article focuses on the evolving role of FDG PET/CT in the diagnosis, radiation therapy planning, therapy assessment, and posttherapy monitoring of CRC and anal cancer. CONCLUSION. FDG PET/CT is a valuable imaging modality that impacts the clinical management of patients with CRC and those with anal cancer.

Original languageEnglish (US)
Pages (from-to)1109-1119
Number of pages11
JournalAmerican Journal of Roentgenology
Volume203
Issue number5
DOIs
StatePublished - Nov 1 2014

Keywords

  • Anal cancer
  • Colorectal cancer
  • PET/CT
  • Radiation therapy planning
  • Therapy assessment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'FDG PET/CT in the management of colorectal and anal cancers'. Together they form a unique fingerprint.

  • Cite this

    Agarwa, A., Marcus, C., Xiao, J., Nene, P., Kachnic, L. A., & Subramaniam, R. M. (2014). FDG PET/CT in the management of colorectal and anal cancers. American Journal of Roentgenology, 203(5), 1109-1119. https://doi.org/10.2214/AJR.13.12256